相关实验视频

Updated: May 24, 2025

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

治疗中取得的进步紧缩性巨细胞瘤:向CSF1/CSF1R轴

Tarek Assi¹, Tania Moussa², Carine Ngo³

¹Division of International Patients Care, Gustave Roussy Cancer Campus, Villejuif, France; Radiology Department, Gustave Roussy Cancer Campus, Villejuif, France.

Cancer treatment reviews

|February 28, 2025

概括

紧缩性巨细胞瘤 (TGCT) 涉及由CSF1.1驱动的异常细胞生长. 向CSF1/CSF1R通路为不可操作或复发的TGCT提供了有前途的全身治疗,改善了结果.

科学领域:

在瘤学瘤学.
整形外科整形外科整形外科
分子生物学分子生物学

背景情况:

长巨细胞瘤 (TGCT) 是一种局部具有侵略性的瘤扩散,影响关节,肌罩和囊.
TGCT病原发生涉及CSF1过度表达,招募和两极化巨细胞到瘤微环境中的M2表型.
手术切除 (全侧切除) 是主要的,但在扩散性疾病中,复发率高 (40-60%) 会导致关节功能障碍和潜在的截肢.

研究的目的:

审查目前对TGCT病理生理学的理解.
探索CSF1/CSF1R抑制剂在不可操作的TGCT中的临床疗效和安全性.
讨论高级TGCT的当代治疗范式.

主要方法:

文献综述侧重于TGCT的生理病理学.
对TGCT中CSF1/CSF1R抑制剂的临床试验数据的分析.
综合有关治疗策略和结果的信息.

主要成果:

CSF1/CSF1R轴是TGCT中验证的治疗点.
CSF1或CSF1R抑制剂已经证明,在不可手术的TGCT患者中,瘤反应和症状功能得到改善.
系统治疗适用于复发性TGCT,不适合进一步的手术.

结论:

针对CSF1/CSF1R途径代表了管理不可操作和反复发生的TGCT的重大进展.
需要进一步研究这些抑制剂的长期疗效和安全性.
CSF1/CSF1R抑制剂提供了一个可行的全身治疗选择,可能减少关节置换或截肢的需要.

关键词:

在CSF1中,CSF1在CSF1中.在CSF1R中,CSF1R是最重要的.癌症癌症癌症癌症这种类型的肉瘤是sarcoma.这是TGCTCT.有针对性的治疗.这是一个紧张的synovial.长结核巨细胞瘤

更多相关视频

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research

Published on: March 29, 2024

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.